Polemos Share Discussion Threads

[urashimataroo] 24/7/2015 17:26

Homeopathic cure for a long ailing company: DILUTION.
"Dilution usually continues well past the point where no molecules of the original substance remain." (Wikipedia guide to homeopathy)
Get well soon, will you?

[squirrel888] 20/7/2015 22:39

The only reason Steinepreis is adding shares is to increase his voting rights.....so that major SHs can vote in favour of reversing the pre-emptive clause & issue more shares.

If all PIs vote against we might stand a slim chance.

[squirrel888] 13/7/2015 16:09

Anyone voting at the AGM ON 24th July.

My vote is as follows:-
1. For
2. For
3. For
4. Against
5. Against

With a footnote "do something viable with this company and stop messing shareholders about".

[urashimataroo] 15/6/2015 12:58

At least they seem to have paid their online provider and/or the software licence fees for their website, because in recent days the POLEMOS online zoo appears to have been open to visitors 24/7. Congratulations.

[12bn12bn] 26/5/2015 08:14

Beware of this poster! Posted on LGO bb.

Alan Oil 22 May'15 - 15:06 - 31503 of 31620 2 0

Guys just a message from DL on twitter - interesting!


"Just bought a large chunk of PLMO - Great investment with CUBAN flavour! LGO next week"

[enshare] 22/5/2015 17:36

This is looking an interesting share at the moment,with the connections here
from the chairman and several other microcaps involved with him and Mr Lenigas
i am wondering if the plan from the outset was to get an asset established in
one of those other minnows like UKOG or LGO and reverse some of the assets in
to Polemos as a seperate play? As things stand Polemos is a very clean shell
with two thirds of its current market cap in cash so is ideal for such a move.

So this could be a unique play this one IMVHO

[nitaroo] 07/5/2015 12:43

Depending on the outcome of the election, Britain might turn away from the European Union and instead look for stronger ties with Russia, thus completing a European power triangle with England in the West (being responsible for financial hocus-pocus), with Russia in the East (continuing to export malware and grotty porn as well as oil and gas) and Greece to the South (providing facilities for rest and recreation for the upper crust of all three participating allies).
What could be the consequences and implications of such a scenario for the Polemos share price (if any)?
Curios.

[risk1] 05/5/2015 19:26

What exactly has been achieved in the last 2 and a half years? How are our investments in tlw ophr and PV doing?????

[squirrel888] 05/5/2015 18:34

Article on AIM shells.

AIM shells continue to be in the news as Gate Ventures (GATE) continues to defy logic, gravity and any other art or science. Looking at the main reversals into shells in 2014 there were some deals that were done at a share price that was more than 50% below the share price prior to the announcement. Even so, there were some excellent share price performances.
It appears likely that Gate will have to do a deal at well below its current price. Management says that Gate has £2.82 million in the bank, while it is still valued at well over 20 times that figure. The latest news from the shell still provides nothing to warrant this valuation.

Johnny Hon has become a consultant to Gate for £4,000/ month, which he appears to be taking in cash rather than shares. He boasts about his connections in China but his record with UK-quoted companies is poor. He was a director of at least five Plus-quoted (ISDX) companies between 2006 and 2010. none of which could be called a success. Two of them, Global Education and Global Entertainment, both left Plus after Atlantic Law, a law firm run by disgraced lawyer Andrew Greystoke, resigned as corporate adviser in 2009. Hon left the boards in the same year.

Hon was also a director of AIM-quoted companies including Chinese gaming and lottery company Betex, which moved from Plus to AIM in March 2006. The quotation was cancelled in October 2007, after problems with the Chinese authorities over allegations about illegal gambling which were subsequently cleared up. Hon resigned as a director in 2008. There was a dispute about money owed by Hon and his group companies to Betex, which claimed £750,000 but settled for £236,000 after paying legal fees of £127,000.

Hon knows Jun Zhu, who bought shares in Gate after the flotation and is a proposed director. Hon introduced Zhu to Gate executive chairman Geoff Morrow, another long-term associate of Hon, before Gate floated. Hon also introduced five of the original shareholders in Gate to Morrow.

But enough of Gate for the time being and on to 2014 reverse takeovers and their pricing performance.

Indicators in 2014

The table covers the main reversals into shells during 2014. The shells covered range from those that were floated as cash shells to those that had a small, existing business but were transformed through the reversal. Some, such as Nasstar (NASA) might not be described as a shell by some people because it already had an existing cloud computing services operation, but the deal transformed it into a profitable and much larger business.

There were some other reversals not included in the table where there was not a large amount of money raised at the time and/or a share element to the consideration or where reversals were into companies that already had a significant business.

I have left Collagen Solutions' (COS) second reverse transaction in the table because it provides an interesting comparison to the original reversal into Healthcare Investment Opportunities in January. The share price fell back after the original reversal, but the performance since the second one, which was done at a share price that was 44% below the original reverse price of 12.5p a share but at the then market price, has been much stronger. The original shell had traded as high as 16.5p in July 2013.

Three of the companies did their reversal and funded it with share issues at a premium to the share price before the deal was announced. All three were shells which had former operations that had been shed prior to the deals.

In the case of AimShell Acquisitions, the shell that mobile payments technology developer Mi-Pay (MPAY) reversed into, the company's net asset value was 36.6p a share, predominantly made up of cash, compared with a market price of 33.5p a share. This means that the share issue at 41p a share was at a 12% premium to NAV - equivalent to £460,000. The share price had not been as high as 41p since 2011 when the company was still known as Autoclenz.

Feedback (FDBK) had a NAV of nearly 0.5p a share and issued shares to acquire its medical technology businesses at a notional price of 1.25p a share (£625,000). That is equivalent to a premium to NAV of £938,000, however, there was no placing at this share price so it is difficult to assess whether this was a realistic price.

Financial adviser Tavistock Investments (TAVI) was the only one of the three companies that issued shares at a large premium to NAV even though the Tavistock share price had already fallen from around 30p a year earlier.

Discount deals

There were 12 companies that issued shares at a discount to the previous market price. Music streaming technology supplier 7Digital (7DIG) had the largest discount. The share price of UBC, the company's previous name, had soared ahead of the reversal and were suspended at 62.5p a share compared with a 27p placing price. That is a 57% discount.

In this case the potential acquisition of the 7Digital business was first announced in November 2013. The terms of the deal were originally expected to be agreed by the end of April 2014 but it took slightly longer than anticipated. The share price had also benefited from the company having a stake in Audioboom (BOOM). The eventual placing price was nearer to the share price prior to the original announcement of the proposed 7Digital deal.

There are ten companies where the share price has fallen below the deal price at some point, while the rest have always at least traded at the deal price or higher, although two of these companies had traded at below the price prior to the reversal announcement.

The overall performance of the shells is good. Excluding Collagen Solutions, there are eight companies trading above their deal price and six trading at a loss. Three of the poor performers are resources companies. The strong performers more than offset the losses made by the other companies.

There are some highly impressive performers. The best is Tiziana Life Sciences (TILS), where the original deal price was less than one-half of the previous market price. Tiziana, which is developing treatments for cancer, has more than made up for that with a 787.5% gain in little more than one year. However, anyone who bought shares five years ago in the company's previous incarnation would still be losing money.

Social media and audio business Audioboom was at one point the best performer after its share price hit 16.63p - a gain of more than 1,000%. The share price has fallen back, but Audioboom is still 358.7% higher. However, Audioboom is not expected to breakeven until the year to November 2016, so there is little to keep the share price up in the short-term except for investor optimism. Any slippage in forecasts could hit the shares.

The other strong performer is OptiBiotix Health (OPTI). Although, like Audioboom, there are no fundamentals to hold up the share price, the human microbiome-based health treatments developer is making good progress towards developing commercial products that can be used to tackle obesity and high cholesterol levels. It will not take OptiBiotix anywhere near as long to develop money making products as it will for Tiziana.

Technology adviser MXC Capital (MXCP) and Premaitha Health (NIPT) are also trading at more than double their reverse transaction prices.

All of the five best performing companies issued shares at a discount to the previous market price. Audioboom did its transaction at the lowest discount - 14% - while the rest had discounts of between one-third and one-half.

Not all shells make a good home

The table includes shells that have found a suitable acquisition, but this is only part of the picture. Not all shells find a suitable acquisition and they run out of time and have their AIM quotation cancelled. Shells have 12 months to satisfy their investing policy before trading in the shares is suspended. There are then a further six months to complete the policy before the quotation is cancelled.

Mercer Resources, Speymill, African Eagle Resources, Cientifica and Galleon Resources have all left AIM in 2015 because of their failure to find an acquisition. Some might eventually return in a new guise but most probably won't.

Iafyds (IAF) does not have much cash, but Henderson (HGG) owns most of the shares so this simplifies the negotiations concerning a reverse takeover. However, Iafyds, which was formerly voltage optimisation technology company VPhase, has not been able to find a suitable deal and the shares are suspended with the board near to making a decision to wind up the company.

The suspension price was 0.0075p, although the share price had been as low as 0.005p having hit 0.0525p just after Iafyds became a shell. The NAV was 0.0005p a share at the end of 2014. So, even the low is ten times the NAV of the company.

Shells can secure a good business, but there is no guarantee that they will, and if the share price gets too far ahead of reality then it will be even more difficult to secure the right acquisition.

Be nice if they got involved in IoT.

[tradejunkie2] 15/4/2015 15:54

Want excitement, trade VED.

[squirrel888] 16/3/2015 20:10

Risk - I don't think much will happen until after the GE. Once Cameron is toast for all the carnage he's seen on his watch. We MAY get to a point of investments. If you read WStirrup on the AG thread, he succinctly puts the markets, cycles & how the demographics affect those in to easy reading. 2018 should see a turn generally in the markets.

DL has been and gone here & only UKOG is having any kind of movement.

How's ISDX doing - generally?

[risk1] 16/3/2015 20:03

When are they going to make an exciting investment? Only thing that has happenned since plmo was formed is buying shares like ophr and raising money will they raise more this year and say a no of investment oppotunities are being considered 😆

[squirrel888] 25/2/2015 22:04

RGF - sleep well. I get that you care enough to keep posting.

I must be the last naive shareholder.

I don't get why you're so interested though.

[squirrel888] 25/2/2015 21:58

Apparently nothing to see here. I think not.

[squirrel888] 25/2/2015 21:57

Never mind the FCA then.

A keen journalist for the truth is what's really needed here.

Plenty to dig around at now.

Proof of which pieces of the business went where, which directors, which staff, which connections.

Time for real, true journalist to dig and reveal.

So how many shares have you RGF. Why your avid interest here?

Who keeps buying shares, from who? And why?

[squirrel888] 25/2/2015 21:54

Sidevalve on iii posted

Finals and end of year aren't too far away, so in need to avoid further embarrassment for the BoD a move is required.

I still see buying up land in HH much like UKOG, then with a nice bit of hype the share price will be well above 0.01p and a further cashbox placing will follow to keep the company going.